 |
 |

Aplastic Anemia and Immunosuppression
 |
 |
| Since this article does not have an abstract, we have provided the first 129 words of the full text and any section headings. |
|
 |
 |
To the Editor: In their article about antithymocyte globulin and cyclosporine for severe aplastic anemia, Dr Rosenfeld and colleagues1 did not discuss Good and colleagues'2 1956 description of an associated syndrome of gammaglobulinemia, presumably due to immune suppression, in patients with benign thymic tumors. In our clinical experience, we have found that this syndrome can be associated with severe aplastic anemia and vitiligo. Although these findings do not necessarily respond to intravenous globulin or antithymocyte globulin, we have found that cyclosporine may lead to a dramatic response. Rosenfeld et al, however, did not indicate whether their patients had signs of immunosuppression, such as hypogammaglobulinemia, hypothyroidism, pernicious anemia, or vitiligo.
Stephen M. Nagy, Jr, MD;
John J. Fisher, MD
Department of Internal Medicine School of Medicine University of California, Davis
1. Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA. 2003;289:1130-1135.
FREE FULL TEXT
2. Good RA. Thymic tumor and acquired agammaglobulinemia: a clinical and experimental study of the immune response. Surgery. 1956;40:1010-1017.
PUBMED
Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.
JAMA. 2003;290:193.
RELATED ARTICLES
Aplastic Anemia and ImmunosuppressionReply
Neal S. Young and Stephen Rosenfeld
JAMA. 2003;290(2):193.
EXTRACT
| FULL TEXT
Antithymocyte Globulin and Cyclosporine for Severe Aplastic Anemia: Association Between Hematologic Response and Long-term Outcome
Stephen Rosenfeld, Dean Follmann, Olga Nunez, and Neal S. Young
JAMA. 2003;289(9):1130-1135.
ABSTRACT
| FULL TEXT
|